Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Adverum Biotechnologies Inc. buy stratec

Start price
€5.80
16.02.18 / 50%
Target price
€7.22
16.08.18
Performance (%)
-18.29%
End price
€4.74
16.08.18
Summary
This prediction ended on 16.08.18 with a price of €4.74. The prediction for Adverum Biotechnologies Inc. disappointed with a performance of -18.29%. stratec has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Adverum Biotechnologies Inc. - - - -
iShares Core DAX® -3.033% -0.013% 11.953% 15.609%
iShares Nasdaq 100 -3.554% -2.546% 30.128% 44.540%
iShares Nikkei 225® -3.938% 2.183% 11.741% 8.345%
iShares S&P 500 -1.517% -0.882% 25.752% 42.388%

Comments by stratec for this prediction

In the thread Adverum Biotechnologies Inc. diskutieren
Prediction Buy
Perf. (%) -18.29%
Target price 7.216
Change
Ends at 16.08.18

stratec stimmt der fundamentalen Bewertung mit dem Ergebnis 'überbewertet' nicht zu


Adverum Biotechnologies (ADVM) was assumed as a Buy at Piper Jaffray Thursday with a $12 price target. Jaffray's analyst believes the company



Prediction Buy
Perf. (%) -18.29%
Target price 7.216
Change
Ends at 16.08.18

(Laufzeit überschritten)